Patent Assignment
Reel/Frame 072445/0769
Patent Security Agreement
Recorded: 2025-08-12
Pages: 26
Assignor
MANNKIND CORPORATION
Executed: 2025-08-06
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
1100 NORTH MARKET STREET, WILMINGTON, DELAWARE, 19890
Covered Properties
(71)
Clofazimine Composition and Method for the Treatment or Prophylaxis of Viral Infections
Application:
17/996,706 →
Publication:
US US20230248722A1
Dry Powder Inhaler and System for Drug Delivery
Application:
16/932,520 →
Publication:
US US20200345957A1
Dry Powder Inhaler
Application:
17/983,915 →
Publication:
US US20230098083A1
Methods and Compositions for Treating Pulmonary Hypertension
Application:
17/975,403 →
Publication:
US US20230130606A1
Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine
Apparatus, System and Method for Detecting and Monitoring Inhalations
Application:
17/931,098 →
Publication:
US US20230001112A1
Methods for the Synthesis of Activated Ethylfumarates and Their Use as Intermediates
Application:
18/978,238 →
Publication:
US US20250109109A1
Fluid Delivery Device Having an Insertable Prefilled Cartridge
Application:
18/946,249 →
Publication:
US US20250065040A1
Method of Preventing Adverse Effects by Glp-1
Application:
17/887,856 →
Publication:
US US20220387593A1
Delivery of Active Agents
Application:
17/864,828 →
Publication:
US US20220362147A1
Blister Package for Pharmaceutical Cartridges
Application:
18/894,568 →
Publication:
US US20250018133A1
Dry Powder Drug Delivery System and Methods
Application:
18/893,801 →
Publication:
US US20250161599A1
High Capacity Diketopiperazine Microparticles and Methods
Application:
17/815,045 →
Publication:
US US20230016875A1
Method and Composition for Treating Lung Diseases
Application:
18/861,479 →
Publication:
US US20250288515A1
Optimization of Dosing and Prescribing of Medication
Application:
18/847,985 →
Publication:
US US20250201377A1
Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them
Application:
17/755,425 →
Publication:
US US20220370444A1
Method and Composition for Treating Obesity
Application:
18/796,217 →
Publication:
US US20240390274A1
Adapter for a Fluid Transfer Device
Dry Powder Inhaler and System for Drug Delivery
Application:
18/745,857 →
Publication:
US US20250090774A1
Formation of N-Protected 3,6-Bis-(4-Aminobutyl)-2,5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester Intermediate
Application:
18/744,031 →
Publication:
US US20240336576A1
Pharmaceutical Compositions and Methods
Application:
18/728,814 →
Publication:
US US20250312419A1
Formulation and Method for Topical Treatment of Mycobacterium Ulcerans in Buruli Ulcers
Application:
18/714,456 →
Publication:
US US20240390366A1
Dry Powder Inhaler
Pharmaceutical Composition for Subcutaneous Administration
Inhalable Dry Powders
Application:
17/593,503 →
Publication:
US US20220241271A1
Method of Treating Hypoglycemia Events in Diabetes Treatment
Application:
18/612,971 →
Publication:
US US20240342251A1
Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
Application:
18/593,204 →
Publication:
US US20240197836A1
Cartridge Insertion Mechanism for a Fluid Delivery Device
Dry Powder Inhaler and System for Drug Delivery
Diketopiperazine Salts for Drug Delivery and Related Methods
Application:
18/524,116 →
Publication:
US US20240115664A1
Fluid Delivery Device
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
Microcrystalline Diketopiperazine Compositions and Methods
Composition and Method for Inhalation
Application:
16/434,938 →
Publication:
US US20190321290A1
Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods Comprising Them
Interactive Apparatus and Method for Real-Time Profiling of Inhalation Efforts
Application:
18/467,580 →
Publication:
US US20240001055A1
Use of Ultrarapid Acting Insulin
Application:
18/440,382 →
Publication:
US US20240181019A1
Methods and Compositions for Treating Pulmonary Hypertension
Application:
18/437,733 →
Publication:
US US20240180897A1
Delivery of Active Agents
Application:
18/434,301 →
Publication:
US US20240197627A1
Reactor for Producing Pharmaceutical Particles in a Precipitation Process
Application:
17/392,361 →
Publication:
US US20210362122A1
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
Application:
18/367,118 →
Publication:
US US20230414500A1
Time Delay Mechanism for a Hydraulic Drug Delivery Device
Application:
18/342,118 →
Publication:
US US20230338645A1
Communication Accessory for a Drug Delivery Device
Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them
Application:
17/309,624 →
Publication:
US US20220023282A1
Moving Basal Engine For A Fluid Delivery Device
Method and Composition for Treating Pulmonary Fibrosis
Application:
18/265,660 →
Publication:
US US20240050374A1
Dry Powder Drug Delivery System
Application:
17/244,730 →
Publication:
US US20210244897A1
Heat-Stable Dry Powder Pharmaceutical Compositions and Methods
Application:
17/241,989 →
Publication:
US US20210244667A1
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Application:
18/235,592 →
Publication:
US US20230390206A1
Prodrugs of Treprostinil
Application:
19/240,421 →
Publication:
US US20250302786A1
Methods for the Manufacture of Diketopiperazine Derivatives
Application:
63/738,039 →
Method and Composition for Treating Lung Diseases
Application:
19/210,846 →
Publication:
US US20250352530A1
Method and Composition for Treating Lung Diseases
Application:
63/696,304 →
Process for Making a Composition for Pulmonary Inhalation
Application:
63/690,929 →
Methods for Treating Non-Tuberculous Mycobacterial Infection
Application:
63/667,070 →
Use of Ultrarapid Acting Insulin
Application:
19/187,193 →
Publication:
US US20250249075A1
Dry Powder Inhaler
Application:
17/158,997 →
Publication:
US US20210146071A1
Method and Composition for Treating Pulmonary Fibrosis
Application:
19/169,921 →
Publication:
US US20250228779A1
Diketopiperazine Microparticles with Defined Specific Surface Areas
Method for Treating Nontuberculous Mycobacterial Infection
Application:
19/109,310 →
Publication:
US US20260069590A1
Dry Powder Inhalation System
Apparatus, System and Method for Detecting and Monitoring Inhalations
Application:
17/077,712 →
Publication:
US US20210361888A1
Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods Comprising Them
Application:
19/047,244 →
Publication:
US US20250177388A1
Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine
Application:
19/027,843 →
Publication:
US US20250163003A1
Formation of N-Protected 3,6-Bis-(4-Aminobutyl)-2,5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester Intermediate
Application:
19/027,772 →
Publication:
US US20250214946A1
Dry Powder Inhaler and System for Drug Delivery
Application:
19/025,827 →
Publication:
US US20250152867A1
Dry Powder Inhaler and System for Drug Delivery
Application:
19/025,214 →
Publication:
US US20250152866A1
Dry Powder Inhaler and System for Drug Delivery
Application:
19/024,729 →
Publication:
US US20250161602A1
Microcrystalline Diketopiperazine Compositions and Methods
Application:
19/022,809 →
Publication:
US US20250154113A1
Diketopiperazine Microparticles with Defined Specific Surface Areas
Application:
19/022,095 →
Publication:
US US20250152579A1
Method and Composition for Administering Prostaglandins
Application:
17/016,158 →
Publication:
US US20200405731A1
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 24, 2020
From: GUARNERI, JOSEPH
To: MANNKIND CORPORATION
Reel/Frame 051909/0371 →
Assignment of Assignor's Interest
Feb 24, 2020
From: KINSEY, P. SPENCER; LAURENZI, BRANDON; SMUTNEY, CHAD C.; ADAMO, BENOIT
To: MANNKIND CORPORATION
Reel/Frame 051909/0337 →
Assignment of Assignor's Interest
Mar 17, 2021
From: SMUTNEY, CHAD C.; KINSEY, P. SPENCER; SAHI, CARL R.; ADAMO, BENOIT
To: MANNKIND CORPORATION
Reel/Frame 055619/0228 →
Assignment of Assignor's Interest
Jun 13, 2022
From: QRUMPHARMA, INC.
To: MANNKIND CORPORATION
Reel/Frame 060182/0018 →
Assignment of Assignor's Interest
Jul 13, 2022
From: LUCERA, ERICK; SALDANHA, JOSEPH
To: VALERITAS INC.
Reel/Frame 060500/0260 →
Extract of Asset Purchase Agreement Covering Ip and Other Business Assets
Jul 13, 2022
From: VALERITAS, INC.
To: ZEALAND PHARMA A/S
Reel/Frame 060649/0694 →
Assignment of Assignor's Interest
Jul 13, 2022
From: INDEPENDENCE AND LIBERTY, LCC
To: VALERITAS, INC.
Reel/Frame 060500/0326 →
Assignment of Assignor's Interest
Jul 13, 2022
From: BARNES, JESSICA W.
To: INDEPENDENCE AND LIBERTY, LCC
Reel/Frame 060500/0280 →
Release of Security Interest
Aug 24, 2022
From: ZOOLANDER SA LLC
To: ZEALAND PHARMA A/S
Reel/Frame 060887/0685 →
Corrective Assignment to Correct the Appl. No. 17262709, Which Should Have Been Appl. No. 17626709 and a Typo in Assignee Name Where Lcc Should Be Llc Previously Recorded at Reel: 060500 Frame: 0280. Assignor(S) Hereby Confirms the Assignment.
Aug 25, 2022
From: BARNES, JESSICA W.
To: INDEPENDENCE AND LIBERTY, LLC
Reel/Frame 061315/0032 →
Assignment of Assignor's Interest
Oct 5, 2022
From: BARNES, JESSICA W.
To: INDEPENDENCE AND LIBERTY, LLC
Reel/Frame 061319/0225 →
Assignment of Assignor's Interest
Oct 12, 2022
From: ZEALAND PHARMA A/S
To: MANNKIND CORPORATION
Reel/Frame 061390/0744 →
Assignment of Assignor's Interest
Nov 1, 2022
From: FREEMAN, JOHN J.; GRANT, MARSHALL L.; ANTUNOVICH, JASON J.; BAY, WILLIAM ELLIOTT
To: MANNKIND CORPORATION
Reel/Frame 061619/0081 →
Assignment of Assignor's Interest
Mar 14, 2023
From: BAUGHMAN, ROBERT A.; RICHARDSON, PETER; LEONE-BAY, ANDREA; COSTELLO, DONALD
To: MANNKIND CORPORATION
Reel/Frame 062982/0282 →
Assignment of Assignor's Interest
Jan 24, 2024
From: POCREVA, JOHN J., III; LAURENZI, BRENDAN; SMUTNEY, CHAD C.; KINSEY, P. SPENCER
To: MANNKIND CORPORATION
Reel/Frame 066225/0455 →
Assignment of Assignor's Interest
Jul 25, 2024
From: GREGORY, CHRISTOPHER
To: VALERITAS, INC.
Reel/Frame 068078/0088 →
Assignment of Assignor's Interest
Jul 25, 2024
From: ZEALAND PHARMA A/S
To: MANNKIND CORPORATION
Reel/Frame 068078/0216 →
Assignment of Assignor's Interest
Jul 25, 2024
From: BARENBOYM, MICHAEL
To: BAREN-BOYM COMPANY
Reel/Frame 068078/0123 →
Assignment of Assignor's Interest
Jul 25, 2024
From: VALERITAS, INC.
To: ZEALAND PHARMA A/S
Reel/Frame 068078/0144 →
Assignment of Assignor's Interest
Jul 25, 2024
From: BAREN-BOYM COMPANY
To: VALERITAS, INC.
Reel/Frame 068078/0129 →
Assignment of Assignor's Interest
Aug 21, 2024
From: FREEMAN, JOHN J.; STAMPER, ADRIENNE; HEITMANN, MELISSA
To: MANNKIND CORPORATION
Reel/Frame 068351/0205 →
Assignment of Assignor's Interest
Sep 20, 2024
From: WADHWA, PREETAMAN KAUR; HARRIS, BENJAMIN; BALKMAN, EMILIE; MCCARTY, KRYSTAL
To: MANNKIND CORPORATION
Reel/Frame 069013/0360 →
Assignment of Assignor's Interest
Dec 12, 2024
From: KRAFT, KELLY S.; FREEMAN, JOHN J.; SERWINSKI, PAUL; PAVIA, VINCENT
To: MANNKIND, CORP
Reel/Frame 069565/0842 →
Release of Security Interest
Dec 16, 2024
From: ZOOLANDER SA LLC
To: ZEALAND PHARMA A/S
Reel/Frame 070672/0456 →
Assignment of Assignor's Interest
Dec 16, 2024
From: ZEALAND PHARMA A/S
To: MANNKIND CORPORATION
Reel/Frame 070432/0904 →